Literature DB >> 15235799

Incidence of virus infection as a cause of Meniere's disease or endolymphatic hydrops assessed by electrocochleography.

Ziane Selmani1, Timo Marttila, Ilmari Pyykkö.   

Abstract

Meniere's disease (MD) may follow viral infection such as by neurotropic viruses known to invade the endolymphatic sac (ES) and provoke endolymphatic hydrops (EH). The objective of this study was to investigate whether neurotropic viruses may cause infection of the inner ear and provoke EH. Antiviral immunoglobulin (IgG) assay against herpes simplex 1 (HSV1), herpes simplex 2 (HSV2), adenovirus (ADV), varicella zoster virus (VZV) and cytomegalovirus (CMV) were performed in 109 patients with an advanced stage of MD and compared with those obtained from 26 patients operated on because of vestibular schwannoma (VS), who served as a control group, to evaluate whether there is an association between the IgG levels and the ECoGs summating potential/action potential ratio (SP/AP ratio) in the MD group. In MD patients, the IgG titre against VZV and ADV were significantly higher than in the control (schwannoma) group. However, no correlation was found between the IgG levels against ADV and VZV with the SP/AP ratio. Neurotropic viruses such VZV and ADV may play a role in the pathogenesis of MD, despite the absence of association between the levels of IgG titres and the SP/AP ratio.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15235799     DOI: 10.1007/s00405-004-0816-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  24 in total

1.  Viral culture and electron microscopy of ganglion cells in Meniere's disease and Bell's palsy.

Authors:  T Palva; L Hortling; J Ylikoski; Y Collan
Journal:  Acta Otolaryngol       Date:  1978 Sep-Oct       Impact factor: 1.494

2.  Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc.

Authors: 
Journal:  Otolaryngol Head Neck Surg       Date:  1995-09       Impact factor: 3.497

3.  Meniere's disease: new temporal bone findings in two cases.

Authors:  R Gussen
Journal:  Laryngoscope       Date:  1971-10       Impact factor: 3.325

4.  Long-term treatment with chlorthalidone reduces experimental hydrops but does not prevent the hearing loss.

Authors:  K C Horner; C Aurousseau; J P Erre; Y Cazals
Journal:  Acta Otolaryngol       Date:  1989 Sep-Oct       Impact factor: 1.494

5.  Ménière's disease as a form of cranial polyganglionitis.

Authors:  K K Adour; F M Byl; R L Hilsinger; R D Wilcox
Journal:  Laryngoscope       Date:  1980-03       Impact factor: 3.325

Review 6.  The role of allergy in Meniere's disease.

Authors:  M J Derebery
Journal:  Otolaryngol Clin North Am       Date:  1997-12       Impact factor: 3.346

7.  Herpes simplex virus antibodies in the perilymph of patients with Menière disease.

Authors:  W Arnold; H P Niedermeyer
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1997-01

8.  Detection of viral DNA in the endolymphatic sac in Ménière's disease by in situ hybridization.

Authors:  Yoshiro Yazawa; Mikio Suzuki; Masakazu Hanamitsu; Hiroshi Kimura; Ikuo Tooyama
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2003 May-Jun       Impact factor: 1.538

9.  Autoimmune reactivity in Ménière's disease: a preliminary report.

Authors:  G B Hughes; S E Kinney; B P Barna; L H Calabrese
Journal:  Laryngoscope       Date:  1983-04       Impact factor: 3.325

10.  Human endolymphatic sac: evidence for a role in inner ear immune defence.

Authors:  H J Altermatt; J O Gebbers; C Müller; W Arnold; J A Laissue
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1990       Impact factor: 1.538

View more
  5 in total

Review 1.  [Surgical therapy in Menière's disease. Historical development and today's state of the art].

Authors:  G Baier; I Ott
Journal:  HNO       Date:  2008-05       Impact factor: 1.284

2.  Hypothyroidism is an independent risk factor for Menière's disease: A population-based cohort study.

Authors:  Wen-Ling Lin; Chih-Yu Chen; Tai-Yi Hsu; Wei-Kung Chen; Cheng-Li Lin; Hang-Cheng Chen
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

3.  Betahistine in the treatment of Ménière's disease.

Authors:  Michel Lacour; Paul H van de Heyning; Miroslav Novotny; Brahim Tighilet
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

Review 4.  Viral causes of hearing loss: a review for hearing health professionals.

Authors:  Brandon E Cohen; Anne Durstenfeld; Pamela C Roehm
Journal:  Trends Hear       Date:  2014-07-29       Impact factor: 3.293

5.  Are viral-infections associated with Ménière's Disease? A systematic review and meta-analysis of molecular-markers of viral-infection in case-controlled observational studies of MD.

Authors:  Nicholas John Dean; Christopher Pastras; Daniel Brown; Aaron Camp
Journal:  PLoS One       Date:  2019-11-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.